Syndromic thrombocytopenia and predisposition to acute myelogenous leukemia caused by constitutional microdeletions on chromosome 21q

Blood

Volumn 112, Issue 4, 2008, Pages 1042-1047

  Shinawi, Marwan ^a   Erez, Ayelet ^a   Shardy, Deborah L ^a,b   Lee, Brendan ^a   Naeem, Rizwan ^a,b   Weissenberger, George ^a   Chinault, A Craig ^a   Cheung, Sau Wai ^a   Plon, Sharon E ^a,b,c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

^c MC3 3320   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORIDE CHANNEL; MEMBRANE PROTEIN; POTASSIUM CHANNEL KCNE1; PROTEIN CLIC6; PROTEIN DSCR; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG; RUNX1 PROTEIN, HUMAN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; CASE REPORT; CHILD; CHROMOSOME 21Q; CHROMOSOME ABERRATION; CLINICAL FEATURE; COMPARATIVE GENOMIC HYBRIDIZATION; DEVELOPMENTAL DISORDER; DISEASE PREDISPOSITION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE MAPPING; GROWTH DISORDER; HUMAN; MALE; MOLECULAR GENETICS; PRIORITY JOURNAL; SCHOOL CHILD; TERATOLOGY; THROMBOCYTOPENIA; CELL CLONE; CHROMOSOME 21; CHROMOSOME DELETION; ERYTHROPOIESIS; GENETIC PREDISPOSITION; GENETICS; MEGAKARYOCYTE; SYNDROME;

CHILD; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 21; CLONE CELLS; CORE BINDING FACTOR ALPHA 2 SUBUNIT; ERYTHROPOIESIS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LEUKEMIA, MYELOID, ACUTE; MEGAKARYOCYTES; SYNDROME; THROMBOCYTOPENIA;

EID: 51649102382     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-01-135970     Document Type: Article

References (25)

1. Hasle H, Clemmensen IH, Mikkelsen M. Risks of leukaemia and solid tumours in individuals with Down's syndrome. Lancet. 2000;355:165-169.
2. Izraeli S, Rainis L, Hertzberg L, Smooha G, Birger Y. Trisomy of chromosome 21 in leukemo- genesis. Blood Cells Mol Dis. 2007;39:156-159.
3. Henry E, Walker D, Wiedmeier SE, Christensen RD. Hematological abnormalities during the first week of life among neonates with Down syndrome: data from a multihospital healthcare system. Am J Med Genet A. 2007;143:42-50.
4. Ferster A, Verhest A, Vamos E, De Maertelaere E, Otten J. Leukemia in atrisomy 21 mosaic: specific involvement of the trisomic cells. Cancer Genet Cytogenet. 1986;20:109-113.
5. Berger R. Acute lymphoblastic leukemia and chromosome 21. Cancer Genet Cytogenet. 1997;94:8-12.
6. Rubnitz JE, Look AT. Molecular genetics of childhood leukemias. J Pediatr Hematol Oncol. 1998; 20:1-11.
7. Look AT. Oncogenic transcription factors in the human acute leukemias. Science. 1997;278:1059-1064.
8. Strefford JC, van Delft FW, Robinson HM, et al. Complex genomic alterations and gene expression in acute lymphoblastic leukemia with intra-chromosomal amplification of chromosome 21. Proc Natl Acad Sci U SA. 2006;103:8167-8172.
9. Song WJ, Sullivan MG, Legare RD, et al. Haplo-insufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia. Nat Genet. 1999;23:166-175.
10. Sun C, Downing JR. Haploinsufficiency of AML1 results in a decrease in the number of LTR-HSCs while simultaneously inducing an increase in more mature progenitors. Blood. 2004;104:3565-3572.
11. Matheny CJ, Speck ME, Cushing PR, et al. Disease mutations in RUNX1 and RUNX2 create nonfunctional, dominant-negative, or hypomorphic alleles. EMBO J. 2007;26:1163-1175.
12. HaradaH, HaradaY, Niimi H, KyoT, Kimura A,
13. Inaba T. High incidence of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome and low blast percentage myeloid leukemia with myelodysplasia. Blood. 2004;103:2316-2324.
14. Osato M. Point mutations in the RUNX1/AML1 gene: another actor in RUNX leukemia. Oncogene. 2004;23:4284-4296.
15. Cheung SW, Shaw CA, Yu W, et al. Development and validation of a CGH microarray for clinical cytogenetic diagnosis. Genet Med. 2005;7:422-432.
16. Ou Z, Kang S-HL, Shaw CA, et al. BAC-emulation oligonucleotide arrays for targeted clinical array-CGH analyses. Genet Med. 2008;10:278-289.
17. Fischbach NA, Rozenfeld S, Shen W, et al. HOXB6 overexpression in murine bone marrow immortalizes a myelomonocytic precursor in vitro and causes hematopoietic stem cell expansion and acute myeloid leukemia in vivo. Blood. 2005; 105:1456-1466.
18. Fröhling S, Scholl C, Bansal D, Huntly BJ. HOX gene regulation in acute myeloid leukemia: CDX marks the spot? Cell Cycle. 2007;6:2241-2245.
19. Chettouh Z, Croquette MF, Delobel B, et al. Molecular mapping of 21 features associated with partial monosomy 21: involvement of the APP-SOD1 region. Am J Hum Genet. 1995;57:62-71.
20. Yao G, Chen XN, Flores-Sarnat L, et al. Deletion of chromosome 21 disturbs human brain morphogenesis. Genet Med. 2006;8:1-7.
21. Warren RJ, Rimoin DL. The G deletion syndromes. J Pediatr. 1970;77:658-663.
22. Huret JL, Leonard C, Chery M, et al. Monosomy 21q: two cases of del(21q) and review of the literature. Clin Genet. 1995;48:140-147.
23. Ks function. Nat Genet. 1997;17:338-340.
24. Schulze-Bahr E, Wang Q, Wedekind H, et al. KCNE1 mutations cause Jervell and Lange-Nielsen syndrome. Nature Genet. 1997;17:267-268.
25. Balduini CL, Iolascon A, SavoiaA. Inherited thrombocytopenias: from genes to therapy. Haematologica. 2002;87:860-880.